Calendar Daihan Pharmaceutical Co.,Ltd.

Equities

A023910

KR7023910003

End-of-day quote Korea S.E. 03:30:00 28/05/2024 am IST 5-day change 1st Jan Change
29,100 KRW 0.00% Intraday chart for Daihan Pharmaceutical Co.,Ltd. +0.34% +4.86%

Chart calendar Daihan Pharmaceutical Co.,Ltd.

97bcc094.R6hBvKISxInjQISHQrmGm_6E7ZpM5aCo2RLFCXbihlM.KIUr3sF9p7DbOrDKM9jk3I_ug-kosNHsn1rzZwWx5TJ2yQ377nqP4pUZ0Q~2fcfc5838f7373915bb0506555dc21fd

Upcoming events on Daihan Pharmaceutical Co.,Ltd.

13/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
05/02/2025 Q4 2024 Earnings Release (Projected)

Past events on Daihan Pharmaceutical Co.,Ltd.

13/05/2024 Q1 2024 Earnings Release (Projected)
20/03/2024 Q4 2023 Earnings Release
14/11/2023 Q3 2023 Earnings Release
11/08/2023 Q2 2023 Earnings Release
15/05/2023 Q1 2023 Earnings Release
17/03/2023 Q4 2022 Earnings Release
14/11/2022 Q3 2022 Earnings Release
17/08/2021 Interim 2021 Earnings Release
17/05/2021 Q1 2021 Earnings Release
10/02/2021 FY 2020 Earnings Release
14/08/2018 Interim 2018 Earnings Release
06/02/2018 FY 2017 Earnings Release

Past dividends on Daihan Pharmaceutical Co.,Ltd.

27/12/2023 Annual 750 KRW
28/12/2022 Annual 650 KRW
29/12/2021 Annual 400 KRW
29/12/2020 Annual 400 KRW
27/12/2019 Annual 400 KRW
27/12/2018 Annual 300 KRW
27/12/2017 Annual 300 KRW
28/12/2016 Annual 220 KRW
29/12/2015 Annual 180 KRW
29/12/2014 Annual 150 KRW

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW
Released
Forecast
Spread
169
168
0.69%
166


171
168
2%
184
183
0.86%
196
197
-0.4%

213

EBITDA
Billions KRW
Released
Forecast
Spread
44,4
43,6
1.87%
41,3


40,5
40,8
-0.79%
42,2
45,6
-7.51%
44,5
45,0
-1.09%

47,8

EBIT
Billions KRW
Released
Forecast
Spread
33,6
34,7
-3.06%
30,0


29,1
28,5
1.99%
33,0
32,8
0.51%
35,8
35,6
0.55%

38,4

Earnings before Tax (EBT)
Billions KRW
Released
Forecast
Spread
37,1
36,7
1.17%
22,5


30,4
30,0
1.44%
33,5
35,9
-6.82%
36,7
36,5
0.64%

39,6

Net income
Billions KRW
Released
Forecast
Spread
28,2
27,6
2.05%
17,4


22,7
23,1
-1.86%
25,0
27,6
-9.56%
28,4
28,4
0.27%

30,8

EPS
KRW
Released
Forecast
Spread
4 694
4 602
2%
2 897


3 778
3 855
-2%
4 171
4 597
-9.27%
4 834
4 730
2.2%

5 132

Announcement Date30/03/2016/03/2109/02/2228/02/2320/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Billions KRW
Released
Forecast
Spread



46,4
44,5
4.38%
48,7
45,9
6.01%
47,8
46,2
3.55%



49,7
49,6
0.13%
50,9
51,5
-1.11%
49,2
50,2
-1.94%
EBIT
Billions KRW
Released
Forecast
Spread



8,35
7,40
12.89%
9,30
8,70
6.89%
7,50
7,30
2.73%



9,12
8,60
6.04%
9,83
9,80
0.26%
7,84
7,90
-0.78%
Net income
Billions KRW
Released
Forecast
Spread
6,18


6,93








7,31











EPS
KRW
Released
Forecast
Spread
1 030


1 156








1 243











Announcement Date16/05/2216/08/2214/11/2228/02/2315/05/2311/08/2314/11/2320/03/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A023910 Stock
  4. Calendar Daihan Pharmaceutical Co.,Ltd.